ArticleActa pharmacologica Sinica2025
Discovery of 5-imidazole-3-methylbenz[d]isoxazole derivatives as potent and selective CBP/p300 bromodomain inhibitors for the treatment of acute myeloid leukemia.
Jian-Kang Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.